Assembly Biosciences Inc
NASDAQ:ASMB
| Market Cap (Intraday) | 317.34M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $25.36 |
| 50-Day MA | $20.63 |
| 200-Day MA | $15.31 |
Assembly Biosciences Inc Stock, NASDAQ:ASMB
Two Tower Place, 7th floor, South San Francisco, California 94080
United States of America
Phone: +1.833.509.4583
Number of Employees: 65
Description
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.